Search research articles
Contact Us
Filters
Showing results (1-10 of 258) with videos related to
Page
of 26
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 23, 2017
More α Than β for Prostate Cancer?
Wolfgang P Fendler, Cathy Cutler
European Urology Focus
|
February 22, 2021
We Can Make a Difference: Investigator-driven Prostate-specific Membrane Antigen Radiotheranostics for Prostate Cancer
Wolfgang P Fendler, Jeremie Calais
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 2017
NTR Is the New SSTR? Perspective for Neurotensin Receptor 1 (NTR)-Directed Theranostics
Wolfgang P Fendler, Richard P Baum
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2021
Nuclear Medicine Beyond VISION
Wolfgang P Fendler, Ken Herrmann, Matthias Eiber
European Urology
|
August 3, 2016
<sup>68</sup>Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging: The New Kid on the Block-Early or Too Early to Draw Conclusions?
Matthias Eiber, Ken Herrmann, Wolfgang P Fendler, et al.
Seminars in Nuclear Medicine
|
December 14, 2025
Treatment response assessment according to updated PROMISE criteria
Tugce Telli, Caner Civan, Ken Herrmann, et al.
Nuclear Medicine Communications
|
April 6, 2016
Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
Wolfgang P Fendler, Christina Bluemel, Domenico Rubello, et al.
European Urology
|
June 24, 2025
Reply to Zhengbo Pan, Run Shi, and Zhaokai Zhou's Letter to the Editor - Re: Madeleine J. Karpinski, Kambiz Rahbar, Martin Bögemann, et al. Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.04.017
Madeleine J Karpinski, Boris A Hadaschik, Wolfgang P Fendler
Expert Review of Molecular Diagnostics
|
September 30, 2016
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer
Martin Barrio, Wolfgang P Fendler, Johannes Czernin, et al.
Radiologie (Heidelberg, Germany)
|
February 17, 2026
[Positron emission tomography in sarcomas]
Wolfgang P Fendler, Lukas Kessler, Stephan Himmen, et al.
Page
of 26
Search research articles
Search
Showing results (1-10 of 258) with videos related to
Sort By:
Page
of 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 23, 2017
More α Than β for Prostate Cancer?
Wolfgang P Fendler, Cathy Cutler
European Urology Focus
|
February 22, 2021
We Can Make a Difference: Investigator-driven Prostate-specific Membrane Antigen Radiotheranostics for Prostate Cancer
Wolfgang P Fendler, Jeremie Calais
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 2017
NTR Is the New SSTR? Perspective for Neurotensin Receptor 1 (NTR)-Directed Theranostics
Wolfgang P Fendler, Richard P Baum
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2021
Nuclear Medicine Beyond VISION
Wolfgang P Fendler, Ken Herrmann, Matthias Eiber
European Urology
|
August 3, 2016
<sup>68</sup>Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging: The New Kid on the Block-Early or Too Early to Draw Conclusions?
Matthias Eiber, Ken Herrmann, Wolfgang P Fendler, et al.
Seminars in Nuclear Medicine
|
December 14, 2025
Treatment response assessment according to updated PROMISE criteria
Tugce Telli, Caner Civan, Ken Herrmann, et al.
Nuclear Medicine Communications
|
April 6, 2016
Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
Wolfgang P Fendler, Christina Bluemel, Domenico Rubello, et al.
European Urology
|
June 24, 2025
Reply to Zhengbo Pan, Run Shi, and Zhaokai Zhou's Letter to the Editor - Re: Madeleine J. Karpinski, Kambiz Rahbar, Martin Bögemann, et al. Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.04.017
Madeleine J Karpinski, Boris A Hadaschik, Wolfgang P Fendler
Expert Review of Molecular Diagnostics
|
September 30, 2016
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer
Martin Barrio, Wolfgang P Fendler, Johannes Czernin, et al.
Radiologie (Heidelberg, Germany)
|
February 17, 2026
[Positron emission tomography in sarcomas]
Wolfgang P Fendler, Lukas Kessler, Stephan Himmen, et al.
Page
of 26